Grown Rogue International Inc. (GRIN.CN)
CAD 0.66
(-1.49%)
CAD 0.66
(-1.49%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 30.16 Million USD | 84.25% |
| 2022 | 16.37 Million USD | 15.22% |
| 2021 | 14.2 Million USD | 277.42% |
| 2020 | 3.76 Million USD | 28.37% |
| 2019 | 2.93 Million USD | -45.35% |
| 2018 | 5.36 Million USD | 16010.56% |
| 2017 | 33.3 Thousand USD | -90.96% |
| 2016 | 368.64 Thousand USD | 424.25% |
| 2015 | 70.31 Thousand USD | -98.56% |
| 2014 | 4.87 Million USD | -25.77% |
| 2013 | 6.56 Million USD | -27.57% |
| 2012 | 9.06 Million USD | -6.41% |
| 2011 | 9.68 Million USD | 68.1% |
| 2010 | 5.75 Million USD | 859.41% |
| 2009 | 600.32 Thousand USD | 205.89% |
| 2008 | 196.25 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 38.49 Million USD | -0.55% |
| 2024 Q2 | 38.7 Million USD | 0.0% |
| 2023 FY | 30.16 Million USD | 84.25% |
| 2023 Q4 | 30.16 Million USD | 10.88% |
| 2023 Q2 | 19.19 Million USD | 2.18% |
| 2023 Q1 | 18.78 Million USD | 14.73% |
| 2023 Q3 | 27.2 Million USD | 41.75% |
| 2022 Q3 | 16.71 Million USD | -4.84% |
| 2022 Q2 | 17.56 Million USD | 8.21% |
| 2022 Q4 | 16.37 Million USD | -2.08% |
| 2022 FY | 16.37 Million USD | 15.22% |
| 2022 Q1 | 16.23 Million USD | 14.27% |
| 2021 Q2 | 8.68 Million USD | 52.24% |
| 2021 Q1 | 5.7 Million USD | 51.56% |
| 2021 Q4 | 14.2 Million USD | 29.19% |
| 2021 FY | 14.2 Million USD | 277.42% |
| 2021 Q3 | 10.99 Million USD | 26.62% |
| 2020 FY | 3.76 Million USD | 28.37% |
| 2020 Q1 | 3.16 Million USD | 8.04% |
| 2020 Q2 | 3.79 Million USD | 19.93% |
| 2020 Q3 | 4.03 Million USD | 6.14% |
| 2020 Q4 | 3.76 Million USD | -6.66% |
| 2019 Q3 | 5.72 Million USD | 4.11% |
| 2019 Q4 | 2.93 Million USD | -48.76% |
| 2019 Q1 | 6.51 Million USD | 21.43% |
| 2019 FY | 2.93 Million USD | -45.35% |
| 2019 Q2 | 5.49 Million USD | -15.64% |
| 2018 Q3 | 25.44 Thousand USD | 131.86% |
| 2018 FY | 5.36 Million USD | 16010.56% |
| 2018 Q4 | 5.36 Million USD | 20992.16% |
| 2018 Q2 | 10.97 Thousand USD | -48.78% |
| 2018 Q1 | 21.42 Thousand USD | -44.22% |
| 2017 FY | 33.3 Thousand USD | -90.96% |
| 2017 Q3 | 33.3 Thousand USD | -63.04% |
| 2017 Q4 | 38.4 Thousand USD | 15.3% |
| 2017 Q2 | 90.12 Thousand USD | -2.53% |
| 2017 Q1 | 92.46 Thousand USD | -32.42% |
| 2016 Q3 | 368.64 Thousand USD | -95.14% |
| 2016 Q1 | 7.07 Million USD | 18184.66% |
| 2016 FY | 368.64 Thousand USD | 424.25% |
| 2016 Q2 | 7.58 Million USD | 7.22% |
| 2016 Q4 | 136.83 Thousand USD | -62.88% |
| 2015 Q3 | 70.31 Thousand USD | -92.55% |
| 2015 FY | 70.31 Thousand USD | -98.56% |
| 2015 Q1 | 4.86 Million USD | 0.96% |
| 2015 Q2 | 943.44 Thousand USD | -80.62% |
| 2015 Q4 | 38.69 Thousand USD | -44.98% |
| 2014 Q3 | 4.87 Million USD | 26.96% |
| 2014 Q2 | 3.83 Million USD | -38.82% |
| 2014 Q1 | 6.27 Million USD | -3.31% |
| 2014 FY | 4.87 Million USD | -25.77% |
| 2014 Q4 | 4.82 Million USD | -1.02% |
| 2013 Q4 | 6.48 Million USD | -1.15% |
| 2013 FY | 6.56 Million USD | -27.57% |
| 2013 Q1 | 9.43 Million USD | -2.36% |
| 2013 Q2 | 9.37 Million USD | -0.7% |
| 2013 Q3 | 6.56 Million USD | -29.98% |
| 2012 Q2 | 9.75 Million USD | 2.04% |
| 2012 Q1 | 9.55 Million USD | 3.94% |
| 2012 Q4 | 9.66 Million USD | 6.68% |
| 2012 Q3 | 9.06 Million USD | -7.12% |
| 2012 FY | 9.06 Million USD | -6.41% |
| 2011 Q1 | 8.41 Million USD | 6.92% |
| 2011 Q2 | 8.91 Million USD | 5.89% |
| 2011 Q4 | 9.19 Million USD | -5.0% |
| 2011 Q3 | 9.68 Million USD | 8.64% |
| 2011 FY | 9.68 Million USD | 68.1% |
| 2010 FY | 5.75 Million USD | 859.41% |
| 2010 Q4 | 7.87 Million USD | 36.67% |
| 2010 Q3 | 5.75 Million USD | 1304.1% |
| 2010 Q2 | 410.19 Thousand USD | -5.91% |
| 2010 Q1 | 435.96 Thousand USD | -12.25% |
| 2009 FY | 600.32 Thousand USD | 205.89% |
| 2009 Q3 | 548.11 Thousand USD | 0.0% |
| 2009 Q4 | 496.84 Thousand USD | -9.35% |
| 2008 FY | 196.25 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aion Therapeutic Inc. | 210.67 Thousand CAD | -14217.385% |
| Ayurcann Holdings Corp. | 14.85 Million CAD | -103.063% |
| Blueberries Medical Corp. | 2.41 Million CAD | -1148.114% |
| The BC Bud Corporation | 632.06 Thousand CAD | -4672.084% |
| BioNxt Solutions Inc. | 1.26 Million CAD | -2279.595% |
| CordovaCann Corp. | 10.26 Million CAD | -193.877% |
| Christina Lake Cannabis Corp. | 15.96 Million CAD | -88.96% |
| Captor Capital Corp. | 33.85 Million CAD | 10.905% |
| City View Green Holdings Inc. | 3846.00 CAD | -784162.116% |
| 1CM Inc. | 34.01 Million CAD | 11.335% |
| Global Hemp Group Inc. | 42.76 Thousand CAD | -70437.922% |
| Greenway Greenhouse Cannabis Corporation | 33.08 Million CAD | 8.844% |
| IM Cannabis Corp. | 48.81 Million CAD | 38.208% |
| Lobe Sciences Ltd. | 2.29 Million CAD | -1211.713% |
| Maple Leaf Green World Inc. | 168.27 Thousand CAD | -17824.873% |
| Mountain Valley MD Holdings Inc. | 8.96 Million CAD | -236.412% |
| Nextleaf Solutions Ltd. | 8.53 Million CAD | -253.316% |
| Ovation Science Inc. | 76.88 Thousand CAD | -39129.426% |
| Pharmadrug Inc. | 1.45 Million CAD | -1966.384% |
| Captiva Verde Wellness Corp. | 9.1 Million CAD | -231.375% |
| RAMM Pharma Corp. | 32.3 Million CAD | 6.618% |
| RIV Capital Inc. | 1.74 Million CAD | -1632.94% |
| Revive Therapeutics Ltd. | 10.63 Million CAD | -183.593% |
| Red White & Bloom Brands Inc. | 234.25 Million CAD | 87.124% |
| SLANG Worldwide Inc. | 33.2 Million CAD | 9.157% |
| 1933 Industries Inc. | 18.01 Million CAD | -67.387% |
| Red Light Holland Corp. | 24.08 Million CAD | -25.24% |
| Top Strike Resources Corp. | 11.73 Million CAD | -157.028% |
| Xebra Brands Ltd. | 379.36 Thousand CAD | -7850.782% |
| Adastra Holdings Ltd. | 32.34 Million CAD | 6.74% |